Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study

Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study

Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer

Bloodless cancer treatment results of patients who do not want blood transfusion: single center experience of 77 cases

Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy

Chemotherapy-related polyneuropathy may deteriorate quality of life in patients with B-cell lymphoma

Clinicopathological Significance of p53, Hypoxia-inducible Factor 1 alpha, and Vascular Endothelial Growth Factor Expression in Colorectal Cancer

Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study

A Phase II Study of Irinotecan With Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-Fluorouracil (Modified FOLFIRI) as First Line Therapy For Patients With Recurrent or Metastatic Gastric Cancer